Marathon Asset Management

NN, Inc. is a diversified industrial company headquartered in Charlotte, North Carolina, that specializes in designing and manufacturing high-precision solutions and components for various markets, including medical, aerospace and defense, electrical, automotive, and general industrial sectors. The company operates through three main segments: Life Sciences, Mobile Solutions, and Power Solutions. The Life Sciences segment focuses on producing high-precision metal and plastic components and assemblies for medical applications, such as surgical devices and implants. The Mobile Solutions segment supplies critical components for fuel systems and automotive applications, while the Power Solutions segment delivers precision components used in power and flight control systems, particularly for military and aerospace applications. With a global presence, NN, Inc. serves customers through its network of manufacturing facilities across North America, South America, Europe, and Asia, employing over 4,300 people dedicated to delivering high-quality precision solutions. Founded in 1980, the company continues to leverage its engineering and materials science expertise to meet the needs of its diverse customer base.

Stockdale Capital Partners is a growing Los Angeles based vertically-integrated real estate investment firm, affiliated with Stockdale Management, a property management firm. We’re championing innovation, sustainability and design that brings people together, enhances quality of life and builds community. Focused on opportunistic investments across the Southwest, we have four offices and 75 employees in four states.

Sunbelt Modular, Inc. is a wholesale manufacturer based in Sachse, Texas, specializing in the design, engineering, and production of commercial modular buildings. Founded in 2006, the company serves a diverse range of industries, including education, healthcare, government, and construction. Sunbelt Modular creates both relocatable and permanent structures, catering to various needs such as classrooms, medical offices, military barracks, and retail kiosks. The firm emphasizes customization, allowing clients to obtain tailored modular solutions for their specific requirements, whether for temporary or permanent use.

GEMS Education is an international network of private schools and educational institutions that offers K-12 education. Founded in 1959 and headquartered in Dubai, United Arab Emirates, GEMS Education has expanded its presence to several locations, including Gurugram, India; New York and Rochester, New York; Riyadh, Saudi Arabia; Verneuil-sur-Avre, France; and Singapore. The company not only provides quality education services from kindergarten to higher grades but also focuses on enhancing government schools and increasing access to education for underprivileged children. By supporting educational initiatives, GEMS Education aims to improve educational standards and assist students in pursuing their career aspirations.

Theratechnologies Inc. is a biopharmaceutical company focused on developing therapeutic products primarily for HIV patients. Founded in 1993 and headquartered in Montreal, Canada, the company utilizes proprietary technologies such as Long Acting Peptides to enhance the stability of therapeutic proteins. Its lead product, tesamorelin, has completed phase III clinical trials for HIV-associated lipodystrophy and is undergoing phase II trials for mild cognitive impairment and growth hormone deficient abdominal obesity. Theratechnologies also has a preclinical product for acute kidney injury. The company markets two approved products: EGRIFTA in Canada and the United States, and Trogarzo, which is also approved for the U.S. market. It engages in various collaborations and licensing agreements, including partnerships with PDC Biotech GmbH and EMD Serono, to address additional medical needs related to HIV. The company's primary revenue source comes from RxCrossroads, a U.S.-based customer.

Acer Therapeutics Inc. is a pharmaceutical company dedicated to the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs. Founded in 2013 and headquartered in Newton, Massachusetts, the company has a diverse clinical pipeline that includes several promising candidates. EDSIVO is designed for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation. ACER-001, a taste-masked formulation of sodium phenylbutyrate, targets various inborn errors of metabolism, including urea cycle disorders and maple syrup urine disease. Additionally, Acer is developing osanetant for the treatment of induced vasomotor symptoms and has initiated research on emetine hydrochloride as a potential COVID-19 treatment in collaboration with the National Center for Advancing Translational Sciences. The company also holds a license agreement with Sanofi for worldwide rights to osanetant.

BigBear.ai is a technology-focused company that specializes in decision intelligence solutions tailored for the national defense and intelligence sectors. The company offers a wide range of high-end capabilities, including artificial intelligence, machine learning, data science, and advanced analytics. Its services encompass offensive and defensive cybersecurity, data management, cloud solutions, digital engineering, and systems integration. BigBear.ai operates through two main segments: Cyber & Engineering and Analytics, serving various markets such as supply chains, logistics, autonomous systems, and cybersecurity. By leveraging its expertise in data and digital technologies, BigBear.ai aims to provide information superiority and robust decision support to its clients.

Kaleo, Inc. is a specialty pharmaceutical company based in Richmond, Virginia, that develops, markets, and sells innovative drug and medical products. Founded in 2008, the company specializes in creating combination drug/device products designed to empower patients in managing their health conditions. Its notable offerings include AUVI-Q, an epinephrine auto-injector for treating severe allergic reactions in infants and small children, and EVZIO, a naloxone injection for opioid overdose. Kaleo's product development emphasizes patient-centric approaches and leverages advanced drug delivery technology to enhance treatment efficacy and safety. The company provides its products through distributors in the United States and Canada and is committed to delivering solutions that improve clinical and economic outcomes for patients and healthcare providers.

Avenger Flight Group, LLC is an aviation training company based in Fort Lauderdale, Florida, incorporated in 2012. The company specializes in commercial aviation simulation and training services, catering to both domestic and international airlines. Avenger Flight Group operates state-of-the-art simulators in strategically located facilities in Fort Lauderdale, Las Vegas, Ciudad de Mexico, and Fort Worth. In addition to simulation training, the company offers classroom instruction tailored for trainers and pilots, providing comprehensive training solutions to meet the needs of its clients.

Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company specializing in medical dermatology therapeutics. The company's lead product candidate, Tapinarof, is a topical cream undergoing Phase III clinical trials for the treatment of psoriasis and atopic dermatitis. Dermavant's pipeline includes additional candidates in various stages of development, such as Cerdulatinib, which targets vitiligo and other inflammatory skin conditions, and Oxybutynin/Pilocarpine, an oral therapy for primary focal hyperhidrosis. Preclinical candidates include DMVT-503, aimed at treating acne vulgaris, and DMVT-501, a potential treatment for atopic dermatitis. Dermavant Sciences has established licensing agreements with several pharmaceutical companies and operates as a subsidiary of Roivant Sciences Ltd. The company, originally known as Roivant Dermatology Ltd., rebranded in June 2016 and is based in London, United Kingdom.

Healogics is a specialized provider of wound care services that operates outpatient wound care centers in hospitals and partners with skilled nursing facilities to address the needs of patients with chronic wounds. The company’s mission is to advance the science of wound medicine and improve treatment outcomes for individuals suffering from various conditions, including diabetes, cancer, and vascular diseases. By collaborating with over 300 skilled nursing facilities and providing inpatient consults at more than 60 partner hospitals, Healogics ensures a comprehensive approach to wound care, combining standard and advanced treatment options to enhance patient recovery.

Europcar is the largest car rental company in Europe, with 2825 locations in 143 countries. The company's offices in Germany, France, Italy, Spain, Portugal, and the United Kingdom are centrally managed by Europcar in France, while other countries operate as franchisees. With a strong presence across Europe, Europcar offers a wide range of car rental services to customers traveling for business or leisure purposes. Through its extensive network of locations, Europcar aims to provide convenient and reliable transportation solutions to meet the diverse needs of its customers.

Baudax Bio is a pharmaceutical company dedicated to developing and commercializing innovative products for hospital and acute care settings. The company's lead product is an intravenous formulation of meloxicam, a non-opioid analgesic that has successfully completed Phase III clinical trials for managing moderate to severe pain. It is currently undergoing Phase IIIb clinical trials to evaluate its effectiveness in reducing opioid consumption and hospital stay lengths in patients undergoing colorectal and orthopedic surgeries. In addition to meloxicam, Baudax Bio is developing early-stage product candidates, including RP1000, an intermediate-acting neuromuscular blocking agent in Phase I trials, and RP2000, an ultrashort-acting neuromuscular blocking agent in preclinical development. The company also has a proprietary intranasal formulation of dexmedetomidine, known as Dex-IN. Incorporated in 2019, Baudax Bio is headquartered in Malvern, Pennsylvania.

Workhorse Group designs and produces battery-electric power trains for its new Workhorse chassis. Workhorse’s approach to building its battery electric power trains uses proven, automotive-grade, mass-produced parts coupled with its custom designed, proprietary control software. Workhorse Group is an original equipment manufacturer of class 3-6 Workhorse brand medium-duty truck chassis. Its assembly plant enables it to build the tried and true W62 chassis and the new, narrower-track W88 chassis at price points and performance specifications sure to be attractive to fleet purchasers. The company's product, The HorseFly™ UAV Delivery system, is a custom built, high efficiency octocopter-based delivery UAV that is fully integrated with electric delivery trucks. It follows the FAA guidelines for UAV operation. The system is designed such that a driver or driver’s assistant can maintain line-of-sight operation of the UAV delivery process. Workhorse Group was founded on 2007 and is headquartered in Loveland, Ohio.

ADMA Biologics, Inc. is a biopharmaceutical company focused on developing, manufacturing, and marketing specialty plasma-derived biologics aimed at treating immune deficiencies and infectious diseases in the United States. The company offers a range of products, including BIVIGAM and ASCENIV, both intravenous immune globulin therapies for primary humoral immunodeficiency, as well as Nabi-HB, which is used for acute exposure to Hepatitis B. ADMA is also involved in the development of additional plasma-derived therapeutics, particularly targeting infections like S. pneumonia. To support its operations, the company runs FDA-licensed source plasma collection facilities known as ADMA BioCenters, which contribute to the supply of plasma necessary for its product manufacturing. ADMA Biologics distributes its products through independent distributors, sales agents, specialty pharmacies, and other healthcare providers. Founded in 2004 and based in Ramsey, New Jersey, ADMA is dedicated to serving niche patient populations, particularly those with compromised immune systems.

Sipex Corporation engages in the design, manufacture, and marketing of analog integrated circuits (ICs). It offers power management products, including white LED drivers, DC/DC regulators, and controllers to regulate, control, monitor, or provide the reference voltage for a system or portion of a system. The company also provides interface products that facilitate the transfer of digital signals between or within electronic systems, as well as ensure connectivity between networks, computers, and digital peripherals and consumer portable devices that connect to them. In addition, it offers optical storage products, including photo-detector ICs, advanced power control ICs, and laser diode drivers.